High-Resolution Ultrasound Perfusion Imaging of Therapeutic Angiogenesis

JACC: Cardiovascular Imaging

Volumn 1, Issue 1, 2008, Pages 83-91

  Rissanen, Tuomas T ^a   Korpisalo, Petra ^a   Karvinen, Henna ^a   Liimatainen, Timo ^b   Laidinen, Svetlana ^a   Gröhn, Olli H ^b   Ylä Herttuala, Seppo ^a,c  

^a Department of Biotechnology and Molecular Medicine ^*

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ECHO CONTRAST MEDIUM; FERUCARBOTRAN; SONOVUE; VASCULOTROPIN 165;

ADIPOSE TISSUE; ANGIOGENESIS; ANGIOGENIC GENE THERAPY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VOLUME; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; GENE TRANSFER; MICROBUBBLE; MICROCIRCULATION; MOUSE; MUSCLE BLOOD FLOW; MUSCLE PERFUSION; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RABBIT; REAL TIME ECHOGRAPHY; SKELETAL MUSCLE;

ADENOVIRIDAE; ADIPOSE TISSUE; ANIMALS; BLOOD VOLUME; CONTRAST MEDIA; FEASIBILITY STUDIES; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MICE; MICROBUBBLES; MODELS, ANIMAL; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHOLIPIDS; RABBITS; REGIONAL BLOOD FLOW; SULFUR HEXAFLUORIDE; TIME FACTORS; ULTRASONOGRAPHY, DOPPLER, PULSED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 41249094115     PISSN: 1936878X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcmg.2007.10.009     Document Type: Article

References (18)

1. Rissanen T.T., and Yla-Herttuala S. Current status of cardiovascular gene therapy. Mol Ther 15 (2007) 1233-1247
2. Yla-Herttuala S., Rissanen T.T., Vajanto I., and Hartikainen J. Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine. J Am Coll Cardiol 49 (2007) 1015-1026
3. Miller J.C., Pien H.H., Sahani D., Sorensen A.G., and Thrall J.H. Imaging angiogenesis: applications and potential for drug development. J Natl Cancer Inst 97 (2005) 172-187
4. Phillips P., and Gardner E. Contrast-agent detection and quantification. Eur Radiol (2004) 14 Suppl 8:4-10
5. Rissanen T.T., Markkanen J.E., Gruchala M., et al. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adeno-viruses. Circ Res 92 (2003) 1098-1106
6. Rissanen T.T., Korpisalo P., Markkanen J.E., et al. Blood flow remodels growing vasculature during vascular endothelial growth factor gene therapy and determines between capillary arterialization and sprouting angiogenesis. Circulation 112 (2005) 3937-3946
7. Krix M., Weber M.A., Krakowski-Roosen H., et al. Assessment of skeletal muscle perfusion using contrast-enhanced ultrasonography. J Ultrasound Med 24 (2005) 431-441
8. Weber M.A., Krix M., and Delorme S. Quantitative evaluation of muscle perfusion with CEUS and with MR. Eur Radiol 17 (2007) 2663-2674
9. Cosgrove D., Eckersley R., Blomley M., and Harvey C. Quantification of blood flow. Eur Radiol 11 (2001) 1338-1344
10. Thijssen J.M., and de Korte C.L. Modeling ultrasound contrast measurement of blood flow and perfusion in biological tissue. Ultrasound Med Biol 31 (2005) 279-285
11. Galbraith S.M., Lodge M.A., Taylor N.J., et al. Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis. NMR Biomed 15 (2002) 132-142
12. Krix M., Kiessling F., Vosseler S., et al. Comparison of intermittent-bolus contrast imaging with conventional power Doppler sonography: quantification of tumour perfusion in small animals. Ultrasound Med Biol 29 (2003) 1093-1103
13. ZJMedia Digital Technology. WinAVI Video Converter. Available at: http://www.winavi.com. Accessed November 29, 2007.
14. Potdevin T.C., Fowlkes J.B., Moskalik A.P., and Carson P.L. Analysis of refill curve shape in ultrasound contrast agent studies. Med Phys 31 (2004) 623-632
15. Leong-Poi H., Kuliszewski M.A., Lekas M., et al. Therapeutic arteriogenesis by ultrasound-mediated VEGF165 plasmid gene delivery to chronically ischemic skeletal muscle. Circ Res 101 (2007) 295-303
16. Thirion C., Lochmuller H., Ruzsics Z., et al. Adenovirus vectors based on human adenovirus type 19a have high potential for human muscle-directed gene therapy. Hum Gene Ther 17 (2006) 193-205
17. Rovai D., DeMaria A.N., and L'Abbate A. Myocardial contrast echo effect: the dilemma of coronary blood flow and volume. J Am Coll Cardiol 26 (1995) 12-17
18. Duerschmied D., Olson L., Olschewski M., et al. Contrast ultrasound perfusion imaging of lower extremities in peripheral arterial disease: a novel diagnostic method. Eur Heart J 27 (2006) 310-315